本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Esperion Therapeutics Inc.

1.17
+0.02001.74%
盘后1.180.0100+0.85%16:47 EDT
成交量:232.17万
成交额:273.18万
市值:2.32亿
市盈率:-1.45
高:1.22
开:1.17
低:1.15
收:1.15
数据加载中...
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/16

重要事件披露

Form 8-K - Current report
2024/12/18

重要事件披露

Form 8-K - Current report
2024/12/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/13

重要事件披露

Form 8-K - Current report
2024/11/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/10/17

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/08/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/12

重要事件披露

Form 8-K - Current report